Vanderbilt Vaccine Center (VVC)
-
October 26, 2017
Vanderbilt leads international effort to develop universal flu vaccine
Researchers at Vanderbilt University Medical Center are leading an international effort to develop a universal influenza vaccine that would protect everyone against all strains of the flu anywhere in the world. -
May 4, 2017
Awards honor contributions, skills of VUMC research staff
Laboratory and administrative personnel at Vanderbilt University Medical Center were honored last week for research excellence during the 13th annual Research Staff Awards luncheon at the University Club. -
April 11, 2017
The Human Vaccines Project, Vanderbilt and Illumina join forces to decode the human immunome
The Human Vaccines Project and Vanderbilt University Medical Center (VUMC) announced this week that they joined forces with Illumina Inc. to decipher the human immunome, the genetic underpinnings of the immune system. -
March 30, 2017
Symposium on modeling immunity set for April 27
The 2017 Vanderbilt Symposium on Modeling Immunity will be held from 1 to 4:30 p.m. Thursday, April 27, in room 1220 MRB III. -
March 2, 2017
Clinical investigation society lauds impact of Crowe’s research
James Crowe Jr., M.D., director of the Vanderbilt Vaccine Center, is the 2017 recipient of the Stanley J. Korsmeyer Award given by the American Society for Clinical Investigation (ASCI), one of the nation’s oldest and most respected honor societies for physician-scientists. -
February 23, 2017
Crowe’s pediatric immune response research lauded
James Crowe Jr., M.D., director of the Vanderbilt Vaccine Center, is the 2017-2018 recipient of the Samuel Rosenthal Prize for Excellence in Academic Pediatrics. -
February 9, 2017
Team isolates new antibodies that may aid RSV vaccine design
Researchers at Vanderbilt University Medical Center (VUMC) have taken another step toward developing a vaccine against respiratory syncytial virus (RSV), the major cause of life-threatening pneumonia in infants worldwide.